福耀玻璃(03606.HK):股東河仁基金會減持2800萬股公司股份,資金將用於賑災救助
格隆匯 7 月 8日丨福耀玻璃(03606.HK)公佈,公司於2020年7月8日收到公司股東河仁基金會的通知,河仁基金會於2020年7月2日至2020年7月8日通過大宗交易方式減持公司股份2800萬股,佔公司總股本的1.12%,在此之前,河仁基金會已於2011月11月減持公司股份1000萬股,以上共計減持公司股份3800萬股,佔公司總股本的1.51%。
此次權益變動後,河仁基金會持有公司股份比例將從11.56%減少至10.44%。此次減持公司股份所獲得的資金將用於賑災救助。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.